RxDoctor Payments Data

Kathryn Bosia, DPM

Podiatrist · Morgantown, WVNPI 1205242435

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Organogenesis Inc. accounts for 78.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $1,349 and has fallen 72.3% since, to $374 in 2025.

$2,299in general payments, 2019–2025

Across 25 payments — averaging $91.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$2K
  • Nevro Corp.$140
  • Stryker$138
  • Paratek Pharmaceuticals, Inc.$82
  • Innovation Technologies Inc$60
  • Ossio Inc$57
  • plus $20 from 1 others

What the payments were for

  • Speaking & faculty fees$824%
  • Travel & lodging$1,15050%
  • Food & beverage$1,06746%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,299 in reported general payments places this provider in the 60th percentile of 37 podiatrist providers in West Virginia.

See all podiatrist providers in West Virginia

Medicare billing

Part B allowed, 2024
$36,438
Medicare patients
177
Services billed
430

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole20$551
Cephalexin17$163
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$107
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$26

Paid to pharmacies, not to this prescriber.

Other podiatrist in Morgantown

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →